What is BFRI's P/E ratio?

BIOFRONTERA INC (BFRI) currently trades at a P/E ratio of 2.79.

BIOFRONTERA INC reports a Return on Equity (ROE) of -182.62%.

What is BFRI's dividend yield?

BIOFRONTERA INC offers a dividend yield of 0.00%.

What is BFRI's Quality Score?

Our AI rates BFRI's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy BFRI?

Our AI Timing Score for BFRI is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does BFRI belong to?

BIOFRONTERA INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange

BFRI (NASDAQ) Stock Analysis | BIOFRONTERA INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

BFRI AI Analysis Summary

Our AI summary for BFRI: BIOFRONTERA INC (NASDAQ), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 2.79, ROE of -182.62%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

BFRI

BIOFRONTERA INC

USD 1.17

-0.06 (-4.88%) Day Change

Watchlist Portfolio Compare Chart

2.79

P/E

0.86

D/E

-182.6%

ROE

-44.7%

ROA

0.00%

Div Yield

BIOFRONTERA INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 1.17 Price -0.06 (-4.88%) Day Change	NEWS SCORE: 96

BFRI, the overall quality is not good ( Quality = 46) but the timing to buy is ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROE is decreasing significantly
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Quality Factors

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	96
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	1.17
PBV / Sector	2.59 / 3.22
Earning Per Share	-0.82

PE / Sector	2.79 / 29.79 GREAT
PEG or PE/Growth / Sector	N/A / 0.13
Average 1M Daily Value	0.46 M GREAT
Average 1W Daily Value	0.72 M GREAT

Timing Factors

85%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

64%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-25.66 / 15.21
NPM Average (%) / Sector	-31.97 / -10.83
NPM Change Average (%) / Sector	620.60 / 117.42 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-44.72 / 8.15
ROA Average (%) / Sector	-47.06 / 2.87
ROA Change Average (%) / Sector	1,402.19 / 112.70
ROE (%) / Sector	-182.62 / -1.02
ROE Average (%) / Sector	-221.29 / 8.35
ROE Change Average (%) / Sector	3,893.09 / 385.91 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.51
Dividend Average (%) / Sector	N/A / 3.06
Dividend Change Average (%) / Sector	N/A / 13.64

Registration Details

Analyze Date	2026-08-01 07:59:32
Symbol	BFRI
Name	BIOFRONTERA INC
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NASDAQ
Listed Shares	12.80 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	15.75 / 10,754.62

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 660 Main Street, Woburn, MA, United States, 01801

Phone: 781 245 1325

Website: https://www.biofrontera-us.com

Employees: 84

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.